Director's Messages

Director's Messages

Subscribe to Director's Messages: National Institute of Neurological Disorders and Stroke (NINDS)RSS

NINDS: Looking Back on 2018

(Monday, January 28, 2019)
As we begin the new year, and on behalf of everyone at NINDS, I would like to thank our investigators, research subjects, and our partners representing those suffering from neurological disorders for helping us make 2018 a success.

A Call to Action: A unique opportunity to advance the effective management of pain while minimizing risk of addiction

(Wednesday, December 19, 2018)
In June 2018, NIH rolled out the Research Plan for the NIH HEAL (Helping to End Addiction Long-termSM) Initiative, a trans-agency effort to speed scientific solutions to the opioid crisis. We are now excited to announce the publication of over 30 Funding Opportunity Announcements (FOAs) for fiscal year 2019.

New and Upcoming Opportunities for Alzheimer’s Disease-Related Dementias (ADRD) Research in Fiscal Year 2019

(Saturday, December 1, 2018)
As the US population ages, the burden of illness due to dementia continues to grow at an alarming rate. 

Honoring Our Inaugural NINDS Landis Mentoring Award Winners in San Diego

(Friday, November 2, 2018)
For so many reasons, I always look forward to the annual meeting of the Society for Neuroscience (SfN), taking place in San Diego this year from November 3-7, 2018.

Now Requesting Your Input: The NIH Blueprint for Neuroscience Research

(Wednesday, October 24, 2018)
Last week, the NIH Blueprint for Neuroscience Research, a group of 14 NIH Institutes, Centers and Offices (ICOs) that support research on the nervous system, released a Request for Information on the Proposed Funding Priorities for Neuroscience Research and Input on Cross-Cutting Opportunities. 

NINDS contributions to deep brain stimulation (DBS) and other devices for neurological disorders

(Friday, October 12, 2018)
In our last two updates to highlight NINDS contributions to therapies for neurological disorders, we focused on a recombinant clot-busting protein for acute stroke, enzyme replacement therapies for lysosomal storage disorders, and an RNA-targeting treatment for spinal muscular atrophy (SMA).

BRAIN 2.0: NIH seeking broad input as it plans the second half of the NIH BRAIN Initiative

(Friday, August 10, 2018)
Researchers funded by the NIH BRAIN Initiative continue to break new ground in scientific discovery and technology development.

Charting the paths to enzyme replacement therapies for lysosomal storage disorders

(Thursday, June 21, 2018)
At the end of January, we launched a new feature on our website that shows how NINDS and the research we support contribute to the discovery and development of treatments for neurological disorders.

The NIH HEAL Initiative and Pain Research

(Tuesday, June 12, 2018)
In last month’s NINDS Director’s message I introduced the planning stages of the NIH HEAL Initiative, Helping to End Addiction Long-term. After months of planning, the HEAL Initiative is being rolled out today in a Viewpoint published in the Journal of the American Medical Association

Making Progress in Glioblastoma

(Wednesday, May 30, 2018)
NINDS Director Walter J. Koroshetz and NCI Director Norman E. Sharpless